NCT02307032|Unknown
Atrial Fibrillation Prediction Trial.
AFPRET
Loading search results
AFPRET
Sponsor study identifier
Secondary identifiers
OTHER · Sismanogleion Hospital Marousi Greece
observational
500
1 country
4
Study Start
September 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Atrial Fibrillation (AF) is a common arrhythmia with a prevalence of 1.5-2%. This prevalence increases significantly after 80 years of age. After the appearance of first episode(s) some of the patients will present frequent arrhythmia recurrences moving from the paroxysmal status to the persistent and the permanent status of the continuous spectrum of the natural time course of AF. In contrast some other will not present further relapses. To study and predict the dynamic evolution of AF is clinically important, furthermore, the detection of different sub populations risk for AF relapses will determine and different therapeutic approaches.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2014
Date type not reportedThis date has not been verified as actual or estimated.
December 1, 2014
Actual (reported)December 3, 2014
Actual (reported)January 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Atrial Fibrillation Relapse
Primary end point is one or more PAF relapse(s) during a period of 12 months after recruitment in study.
12 months
Permanent Atrial Fibrillation
36 months
The study will include \> 500 patients 30-80 years old.
Contact the study team to confirm eligibility.
Cardiology Department, Hippokration Hospital
Athens, Attica, Greece
First Department of Cardiology, Medical School, National & Kapodistrian University of Athens
Athens, Attica, Greece
Cardiology Department Thriasio Hospital
Eleysina, Attica, Greece
Cardiology Department, Sismanogleion Hospital
Petros Arsenos, MD, PhD
First Department of Cardiology, Medical School, National & Kapodistrian University of Athens, Greece
First Submitted
December 1, 2014
First Posted
December 3, 2014
Study Start
September 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2019
Development of an AF Specific Quality of Life Questionnaire: AF-PROMS
Marousi, Greece
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
January 28, 2016
Record last verified: 2016-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: